Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1038/s41598-020-67749-1

http://scihub22266oqcxt.onion/10.1038/s41598-020-67749-1
suck pdf from google scholar
32616763!7331818!32616763
unlimited free pdf from europmc32616763    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid32616763      Sci+Rep 2020 ; 10 (1): 10895
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • A candidate multi-epitope vaccine against SARS-CoV-2 #MMPMID32616763
  • Kar T; Narsaria U; Basak S; Deb D; Castiglione F; Mueller DM; Srivastava AP
  • Sci Rep 2020[Jul]; 10 (1): 10895 PMID32616763show ga
  • In the past two decades, 7 coronaviruses have infected the human population, with two major outbreaks caused by SARS-CoV and MERS-CoV in the year 2002 and 2012, respectively. Currently, the entire world is facing a pandemic of another coronavirus, SARS-CoV-2, with a high fatality rate. The spike glycoprotein of SARS-CoV-2 mediates entry of virus into the host cell and is one of the most important antigenic determinants, making it a potential candidate for a vaccine. In this study, we have computationally designed a multi-epitope vaccine using spike glycoprotein of SARS-CoV-2. The overall quality of the candidate vaccine was validated in silico and Molecular Dynamics Simulation confirmed the stability of the designed vaccine. Docking studies revealed stable interactions of the vaccine with Toll-Like Receptors and MHC Receptors. The in silico cloning and codon optimization supported the proficient expression of the designed vaccine in E. coli expression system. The efficiency of the candidate vaccine to trigger an effective immune response was assessed by an in silico immune simulation. The computational analyses suggest that the designed multi-epitope vaccine is structurally stable which can induce specific immune responses and thus, can be a potential vaccine candidate against SARS-CoV-2.
  • |Angiotensin-Converting Enzyme 2[MESH]
  • |Antibody Affinity/immunology[MESH]
  • |Betacoronavirus/chemistry/genetics/*immunology[MESH]
  • |COVID-19[MESH]
  • |Coronavirus Infections/*prevention & control/virology[MESH]
  • |Epitopes, B-Lymphocyte/*immunology[MESH]
  • |Epitopes, T-Lymphocyte/*immunology[MESH]
  • |Histocompatibility Antigens/immunology[MESH]
  • |Humans[MESH]
  • |Molecular Docking Simulation[MESH]
  • |Molecular Dynamics Simulation[MESH]
  • |Pandemics/*prevention & control[MESH]
  • |Peptidyl-Dipeptidase A/metabolism[MESH]
  • |Phylogeny[MESH]
  • |Pneumonia, Viral/*prevention & control/virology[MESH]
  • |Protein Structure, Tertiary[MESH]
  • |SARS-CoV-2[MESH]
  • |Spike Glycoprotein, Coronavirus/chemistry/*immunology/metabolism[MESH]
  • |Toll-Like Receptor 2/immunology/metabolism[MESH]
  • |Toll-Like Receptor 4/immunology/metabolism[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box